Dr. Michael Ringel has been at BCG 25 years and is currently Managing Director and Senior Partner. He is on the Board of Hevolution US, the charitable organization focused on extending healthy aging for the benefit of all humanity, the Board of AFAR, one of the oldest organizations supporting healthy aging through biomedical research, and an active advocate for longevity science and innovation. Dr. Ringel holds a B.A. summa cum laude in biology from Princeton University, a Ph.D. in biology from Imperial College, and a J.D. cum laude from Harvard Law School.
